Skip Header

15 results for author:"Moore R.A." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (139)

Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.

Pugh T.J., Keyes M., Barclay L., Delaney A., Krzywinski M., Thomas D., Novik K., Yang C., Agranovich A., McKenzie M. et al.

Clin. Cancer Res. 15:5008-5016(2009) · Mapped (19)

Hemin interactions and alterations of the subcellular localization of prion protein.

Lee K.S., Raymond L.D., Schoen B., Raymond G.J., Kett L., Moore R.A., Johnson L.M., Taubner L., Speare J.O., Onwubiko H.A. et al.

J. Biol. Chem. 282:36525-36533(2007) · Mapped (8)

Critical catalytic functional groups in the mechanism of aspartate-beta-semialdehyde dehydrogenase.

Blanco J., Moore R.A., Faehnle C.R., Viola R.E.

Acta Crystallogr. D Biol. Crystallogr. 60:1808-1815(2004) · Mapped (1)

Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans.

Gavin T.P., Stallings H.W., Zwetsloot K.A., Westerkamp L.M., Ryan N.A., Moore R.A., Pofahl W.E., Hickner R.C.

J. Appl. Physiol. 98:315-321(2005) · Mapped (7)

The role of substrate-binding groups in the mechanism of aspartate-beta-semialdehyde dehydrogenase.

Blanco J., Moore R.A., Faehnle C.R., Coe D.M., Viola R.E.

Acta Crystallogr. D 60:1388-1395(2004) · UniProtKB (1)

Capture of an intermediate in the catalytic cycle of L-aspartate-beta-semialdehyde dehydrogenase.

Blanco J., Moore R.A., Viola R.E.

Proc. Natl. Acad. Sci. U.S.A. 100:12613-12617(2003) · UniProtKB (1)

Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.

Tribuddharat C., Moore R.A., Baker P., Woods D.E.

Antimicrob. Agents Chemother. 47:2082-2087(2003) · UniProtKB (5)

Purification and preliminary characterization of brain aspartoacylase.

Moore R.A., Le Coq J., Faehnle C.R., Viola R.E.

Arch. Biochem. Biophys. 413:1-8(2003) · UniProtKB (1) · Mapped (4)

A structural basis for the mechanism of aspartate-beta-semialdehyde dehydrogenase from Vibrio cholerae.

Blanco J., Moore R.A., Kabaleeswaran V., Viola R.E.

Protein Sci. 12:27-33(2003) · UniProtKB (1)

Expression and purification of aspartate beta-semialdehyde dehydrogenase from infectious microorganisms.

Moore R.A., Bocik W.E., Viola R.E.

Protein Expr. Purif. 25:189-194(2002) · UniProtKB (4)

Synthesis and evaluation of alternative substrates for arginase.

Han S., Moore R.A., Viola R.E.

Bioorg. Chem. 30:81-94(2002) · Mapped (1)

Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7).

Gibb A.P., Tribuddharat C., Moore R.A., Louie T.J., Krulicki W., Livermore D.M., Palepou M.F., Woodford N.

Antimicrob. Agents Chemother. 46:255-258(2002) · UniProtKB (3)

Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.

Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods D.E.

Antimicrob. Agents Chemother. 43:465-470(1999) · UniProtKB (3)

A transgenic myogenic cell line lacking ryanodine receptor protein for homologous expression studies: reconstitution of Ry1R protein and function.

Moore R.A., Nguyen H., Galceran J., Pessah I.N., Allen P.D.

J. Cell Biol. 140:843-851(1998) · Mapped (2)

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.

Moore R.A., Beckthold B., Wong S., Kureishi A., Bryan L.E.

Antimicrob. Agents Chemother. 39:107-111(1995) · UniProtKB (1)

to top of page·

Page 1 of 1